Hologic Enters the Viral Load Market with CE Mark Certification for the Aptima HIV-1 Viral Load Test
BEDFORD, Massachusetts, Dec. 1, 2014 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX), today announced CE mark certification for its new Aptima HIV-1 Quant Dx assay for use on the Company's Panther system ...
MARLBOROUGH, Massachusetts, Jan. 16, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that its CE-marked Aptima ® HIV-1 Quant Dx assay has been awarded World Health Organization (WHO) ...
Hologic, Inc. HOLX recently received CE mark for its new Aptima CMV Quant assay in Europe to quantify human cytomegalovirus (CMV). Notably, Aptima CMV Quant assay is the first in a new line of Hologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results